Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas

International Journal of Cancer

Volumn 64, Issue 4, 1995, Pages 280-285

  Bellacosa, Alfonso ^a   De Feo, Daniela ^a   Godwin, Andrew K ^c   Bell, Daphne W ^c   Cheng, Jin Quan ^c   Altomare, Deborah A ^c   Wan, Minghong ^d   Dubeau, Louis ^d   Scambia, Giovanni ^b   Masciullo, Valeria ^b   Ferrandina, Gabriella ^b   Panici, Pierluigi Benedetti ^b   Mancuso, Salvatore ^b   Neri, Giovanni ^a   Testa, Joseph R ^c  

^a University of Rome   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c FOX CHASE CANCER CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; BREAST NEOPLASMS; CARCINOMA, INFILTRATING DUCT; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; MIDDLE AGE; ONCOGENE PROTEINS; OVARIAN NEOPLASMS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENES; RNA, MESSENGER; RNA, NEOPLASM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029127042     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910640412     Document Type: Article

References (30)

1. The proteins encoded by c‐akt and v‐akt differ in post‐translational modification, subcellular localization and oncogenic potential
2. Amplification of c‐erbB‐2 and aggressive human breast tumors?
3. c‐myc amplification in ovarian cancer
4. A retroviral oncogene, Akt, encoding a serine‐threonine kinase containing an SH2‐like region
5. Oncogenes and clinical cancer
6. Amplification of N‐MYC in untreated human neuroblastomas correlates with advanced disease stage
7. Akt2, a putative oncogene encoding a member of a subfamily of protein serine/threonine kinases, is amplified in human ovarian carcinomas
8. Single‐step method of RNA isolation by acid guanidinium thiocyanate‐phenol‐chloroform extraction
9. The human MYC gene family: structure and activity of L‐MYC and an L‐MYC pseudogene
10. Revision of the standards for the assessment of hormone receptors in human breast cancer
11. Genetic alteration of the c‐myc protooncogene (MYC) in human primary breast carcinomas
12. Oncogenes and anti‐oncogenes in gynecologic malignancies
13. PRAD‐1/cyclin Dl gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas
14. MYC family oncogene amplification in tumor cell lines established from small‐cell lung‐cancer patients and its relationship to clinical status and course
15. Non parametric estimation from incomplete observation
16. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to
17. Evaluation of survival data and two new rank order statistics arising in its consideration
18. A strong candidate for the breast and ovarian cancer susceptibility gene
19. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma
20. The candidate proto‐oncogene bcl‐3 is related to genes implicated in cell lineage determination and cell cycle control
21. Chromosome aberrations in 35 primary ovarian carcinomas
22. Report of the Committee on the genetic constitution of chromosome 19
23. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors
24. Significance of epidermal growth factor receptor in advanced ovarian cancer
25. Studies of the HER‐2/neu proto‐oncogene in human breast and ovarian cancer
26. Origin of human cancer revisited
27. Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexities
28. Cancer of the ovary